Abstract
A novel, sensitive, stability indicating RP-LC method has been developed for the quantitative determination of mitotane, its impurity in both bulk drugs and pharmaceutical dosage forms. Efficient chromatographic separation was achieved using a C18 stationary phase with simple mobile phase combination delivered in an isocratic mode and quantitation was by ultraviolet detection at a wavelength of 230 nm. The mobile phase consisted of buffer and acetonitrile (25:75, v/v) delivered at a flow rate of 1.0 mL min−1. Buffer consisted of 10 mM potassium dihydrogen orthophosphate monohydrate, pH adjusted to 2.5 by orthophosphoric acid. In the developed LC method the resolution (R s ) between mitotane and its impurity namely Imp-1 was found to be greater than 2.5. Regression analysis shows an r value (correlation coefficient) greater than 0.999 for mitotane and its impurity. This method was capable to detect the impurity of mitotane at a level of 0.003% with respect to test a concentration of 0.2 mg mL−1 for a 10 μL injection volume. The inter- and intra-day precision values for mitotane and its impurity was found to be within 2.0% RSD. The method has shown good and consistent recoveries for mitotane in bulk drugs (99.2–101.5%), pharmaceutical dosage forms (98.2–103.1%) and for its impurity (99.7–102.1%). The test solution was found to be stable in diluent for 48 h. The drug was subjected to stress conditions of hydrolysis, oxidation, photolysis and thermal degradation. Considerable degradation was found to occur in basic stress hydrolysis. The stress samples were assayed against a qualified reference standard and the mass balance was found close to 99.97%. The developed RP-LC method was validated with respect to linearity, accuracy, precision and robustness.
Similar content being viewed by others
References
Touitou Y, Bogdan A, Legrand JC, Desgrez P (1977) Ann Endocrinol (Paris) 38(1):13–25
Gebhardt DO, Moolenaar AJ, van Seters AP, van der Velde EA, Gevers Leuven JA (1992) Cancer Chemother Pharmacol 29:331–334
Haak HR, Hermans J, van de Velde CJ, Lentjes EG, Goslings BM, Fleuren GJ, Krans HM (1994) Br J Cancer 69(5):947–951
Baudin E, Pellegriti G, Bonnay M, Penfornis A, Laplanche A, Vassal G, Schlumberger M (2001) Cancer 92(6):1385–1392
Jones RB, Frank R, Mass T (1983) CA Cancer J Clin 33:258–263. doi:10.3322/canjclin.33.5.258
Terzolo M, Pia A, Berruti A, Osella G, Alì A, Carbone V, Testa E, Dogliotti L, Angeli A (2000) J Clin Endocrinol Metab 85:2234–2238
De Francia S, Pirro E, Zappia F, De Martino F, Sprio AE, Daffara F, Terzolo M, Berruti A, Di Carlo F, Ghezzo F (2006) J Chromatogr B Analyt Technol Biomed Life Sci 837:69–75
Ali I, Aboul-Enein HY (2002) Environ Toxicol 17(4):329–333
Andersen A, Kasperlik-Zaluska AA, Warren DJ (1999) Ther Drug Monit 21(3):355–359
Andersen A, Warren DJ, Nome O, Vesterhus L, Slørdal L (1995) Ther Drug Monit 17(5):526–531
Benecke R, Keller E, Vetter B, de Zeeuw RA (1991) Eur J Clin Pharmacol 41(3):259–261
Musial SP, Freeman CJ, Sinsheimer JE (1985) J Chromatogr 319(3):467–470
Moolenaar AJ, Niewint JW, Oei IT (1977) Clin Chim Acta 76(2):213–218
Benecke R, Vetter B, De Zeeuw RA (1987) J Chromatogr 417(2):287–294
Sinsheimer JE, Counsell RE, Cai W, Gopalaswamy R, Mahalakshmi P, Piñeiro-Sánchez ML, Ruangwises N, Schteingart DE (1996) J Pharm Biomed Anal 14(7):861–866. doi:10.1016/0731-7085(96)01729-3
Inouye M, Mio T, Sumino K (1987) Clin Chim Acta 170(2–3):305–314
Leutenegger M, Caron J, Couchot J, Gross A, Maes B, Enger A, Millart H (1977) Nouv Presse Med 6(7):566
Morishita K, Okumura H, Takahashi N (2001) Toxicology 165(2–3):171–178. doi:10.1016/s0300-483X(01)00431-0
USP (2008) United States pharmacopoeia, 31st edn. United States Pharmacopeial Convention, Rockville
ICH guidelines on Validation of Analytical procedures, Text and Methodology Q2 (R1), FDA, Published in the Federal Register (1995) 60:11260
Bakshi M, Singh S (2002) J Pharm Biomed Anal 28:1011–1040
Acknowledgments
The authors wish to thank the management of United States Pharmacopeia laboratory-India for supporting this work.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kaja, R.K., Surendranath, K.V., Radhakrishnanand, P. et al. A Validated Stability Indicating LC Method for Mitotane in Bulk Drugs and Pharmaceutical Dosage Forms. Chroma 69, 1407–1412 (2009). https://doi.org/10.1365/s10337-009-1051-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1365/s10337-009-1051-x